Is Enhancing cGMP-PKG Signalling a Promising Therapeutic Target for Heart Failure With Preserved Ejection Fraction?

Netherlands Heart Journal - Netherlands
doi 10.1007/s12471-016-0814-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Heart Rate in Heart Failure With Preserved Ejection Fraction: Target or Marker?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Spironolactone for Heart Failure With Preserved Ejection Fraction

New England Journal of Medicine
Medicine
2014English

Heart Failure With Preserved Ejection Fraction Is a Highly Arrhythmogenic Disease

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Prognosis in Heart Failure With Preserved Ejection Fraction

sudan heart journal
2017English

Ischaemia in Heart Failure With Preserved Ejection Fraction; Is It Important?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2016English

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2019English

Prognosis of Heart Failure With Stable Mid-Range Ejection Fraction in Comparison to Heart Failure With Stable Reduced Ejection Fraction and Heart Failure With Stable Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

CAD Is a Risk Factor for Heart Failure With Preserved Ejection Fraction: The ARIC Study

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Derangements in Adrenergic-Adipokine Signalling Establish a Neurohormonal Basis for Obesity-Related Heart Failure With a Preserved Ejection Fraction

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy